This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
ProPhase Labs, Inc. manufactures, markets, and distributes a range of homeopathic and health products in the United States. The company also researches and develops over-the-counter (OTC) drugs, natural base health products with supplements, personal care, and cosmeceutical products.View PRPH key stats
ProPhase Labs Inc - PRPH - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates ProPhase Labs Inc as a
Sell with a ratings score of D.
Report Snippet: We rate PROPHASE LABS INC (PRPH) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.